Canonical and Noncanonical Hedgehog/GLI Signaling in Hematological Malignancies

Vitamins and Hormones

Volumn 88, Issue , 2012, Pages 25-54

  Aberger, Fritz ^a   Kern, Daniela ^a   Greil, Richard ^b   Hartmann, Tanja Nicole ^b  

^a UNIVERSITY OF SALZBURG   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

CLL; GLI; Hedgehog; Hematological malignancy; Noncanonical

Indexed keywords

EID: 84857723465     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394622-5.00002-X     Document Type: Chapter

References (131)

1. Abe Y., Oda-Sato E., Tobiume K., Kawauchi K., Taya Y., Okamoto K., Oren M., Tanaka N. Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Proc. Natl. Acad. Sci. USA 2008, 105:4838-4843.
2. Aza-Blanc P., Ramirez-Weber F.A., Laget M.P., Schwartz C., Kornberg T.B. Proteolysis that is inhibited by hedgehog targets Cubitus interruptus protein to the nucleus and converts it to a repressor. Cell 1997, 89:1043-1053.
3. Bailey J.M., Swanson B.J., Hamada T., Eggers J.P., Singh P.K., Caffery T., Ouellette M.M., Hollingsworth M.A. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin. Cancer Res. 2008, 14:5995-6004.
4. Barakat M.T., Humke E.W., Scott M.P. Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer. Trends Mol. Med. 2010, 16:337-348.
5. Beachy P.A., Karhadkar S.S., Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004, 432:324-331.
6. Beauchamp E., Bulut G., Abaan O., Chen K., Merchant A., Matsui W., Endo Y., Rubin J.S., Toretsky J., Uren A. GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein. J. Biol. Chem. 2009, 284:9074-9082.
7. Beauchamp E.M., Ringer L., Bulut G., Sajwan K.P., Hall M.D., Lee Y.C., Peaceman D., Ozdemirli M., Rodriguez O., Macdonald T.J., Albanese C., Toretsky J.A., et al. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. J. Clin. Invest. 2011, 121:148-160.
8. Berman D.M., Karhadkar S.S., Maitra A., Montes De Oca R., Gerstenblith M.R., Briggs K., Parker A.R., Shimada Y., Eshleman J.R., Watkins D.N., Beachy P.A. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003, 425:846-851.
9. Bhardwaj G., Murdoch B., Wu D., Baker D.P., Williams K.P., Chadwick K., Ling L.E., Karanu F.N., Bhatia M. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat. Immunol. 2001, 2:172-180.
10. Brewster R., Mullor J.L., Ruiz i Altaba A. Gli2 functions in FGF signaling during antero-posterior patterning. Development 2000, 127:4395-4405.
11. Buonamici S., Williams J., Morrissey M., Wang A., Guo R., Vattay A., Hsiao K., Yuan J., Green J., Ospina B., Yu Q., Ostrom L., et al. Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci. Transl. Med. 2010, 2:51ra70.
12. Burger J.A., Tsukada N., Burger M., Zvaifler N.J., Dell'Aquila M., Kipps T.J. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 2000, 96:2655-2663.
13. Chen J.K., Taipale J., Cooper M.K., Beachy P.A. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 2002, 16:2743-2748.
14. Chen J.K., Taipale J., Young K.E., Maiti T., Beachy P.A. Small molecule modulation of Smoothened activity. Proc. Natl. Acad. Sci. USA 2002, 99:14071-14076.
15. Chen Y., Sasai N., Ma G., Yue T., Jia J., Briscoe J., Jiang J. Sonic Hedgehog dependent phosphorylation by CK1alpha and GRK2 is required for ciliary accumulation and activation of Smoothened. PLoS Biol. 2011, 9:e1001083.
16. de The H., Chen Z. Acute promyelocytic leukaemia: Novel insights into the mechanisms of cure. Nat. Rev. Cancer 2010, 10:775-783.
17. Dennler S., Andre J., Verrecchia F., Mauviel A. Cloning of the human GLI2 Promoter: Transcriptional activation by transforming growth factor-beta via SMAD3/beta-catenin cooperation. J. Biol. Chem. 2009, 284:31523-31531.
18. Desch P., Asslaber D., Kern D., Schnidar H., Mangelberger D., Alinger B., Stoecher M., Hofbauer S.W., Neureiter D., Tinhofer I., Aberger F., Hartmann T.N., et al. Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells. Oncogene 2010, 29:4885-4895.
19. Di Marcotullio L., Ferretti E., Greco A., De Smaele E., Po A., Sico M.A., Alimandi M., Giannini G., Maroder M., Screpanti I., Gulino A. Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination. Nat. Cell Biol. 2006, 8:1415-1423.
20. Dierks C., Grbic J., Zirlik K., Beigi R., Englund N.P., Guo G.R., Veelken H., Engelhardt M., Mertelsmann R., Kelleher J.F., Schultz P., Warmuth M. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat. Med. 2007, 13:944-951.
21. Dierks C., Beigi R., Guo G.R., Zirlik K., Stegert M.R., Manley P., Trussell C., Schmitt-Graeff A., Landwerlin K., Veelken H., Warmuth M. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 2008, 14:238-249.
22. Dotto G.P. Notch tumor suppressor function. Oncogene 2008, 27:5115-5123.
23. Drakopoulou E., Outram S.V., Rowbotham N.J., Ross S.E., Furmanski A.L., Saldana J.I., Hager-Theodorides A.L., Crompton T. Non-redundant role for the transcription factor Gli1 at multiple stages of thymocyte development. Cell Cycle 2010, 9:4144-4152.
24. El Andaloussi A., Graves S., Meng F., Mandal M., Mashayekhi M., Aifantis I. Hedgehog signaling controls thymocyte progenitor homeostasis and differentiation in the thymus. Nat. Immunol. 2006, 7:418-426.
25. Epstein E.H. Basal cell carcinomas: Attack of the hedgehog. Nat. Rev. Cancer 2008, 8:743-754.
26. Ericson J., Morton S., Kawakami A., Roelink H., Jessell T.M. Two critical periods of Sonic Hedgehog signaling required for the specification of motor neuron identity. Cell 1996, 87:661-673.
27. Fan Q., He M., Sheng T., Zhang X., Sinha M., Luxon B., Zhao X., Xie J. Requirement of TGFbeta signaling for SMO-mediated carcinogenesis. J. Biol. Chem. 2010, 285:36570-36576.
28. Ferretti E., De Smaele E., Miele E., Laneve P., Po A., Pelloni M., Paganelli A., Di Marcotullio L., Caffarelli E., Screpanti I., Bozzoni I., Gulino A. Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J. 2008, 27:2616-2627.
29. Fogarty M.P., Emmenegger B.A., Grasfeder L.L., Oliver T.G., Wechsler-Reya R.J. Fibroblast growth factor blocks Sonic hedgehog signaling in neuronal precursors and tumor cells. Proc. Natl. Acad. Sci. USA 2007, 104:2973-2978.
30. Gallet A. Hedgehog morphogen: From secretion to reception. Trends Cell Biol. 2011, 21:238-246.
31. Gao J., Graves S., Koch U., Liu S., Jankovic V., Buonamici S., El Andaloussi A., Nimer S.D., Kee B.L., Taichman R., Radtke F., Aifantis I. Hedgehog signaling is dispensable for adult hematopoietic stem cell function. Cell Stem Cell 2009, 4:548-558.
32. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat. Rev. Cancer 2002, 2:48-58.
33. Hahn H., Wojnowski L., Specht K., Kappler R., Calzada-Wack J., Potter D., Zimmer A., Muller U., Samson E., Quintanilla-Martinez L. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. J. Biol. Chem. 2000, 275:28341-28344.
34. Hallahan A.R., Pritchard J.I., Hansen S., Benson M., Stoeck J., Hatton B.A., Russell T.L., Ellenbogen R.G., Bernstein I.D., Beachy P.A., Olson J.M. The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res. 2004, 64:7794-7800.
35. Hartmann W., Koch A., Brune H., Waha A., Schuller U., Dani I., Denkhaus D., Langmann W., Bode U., Wiestler O.D., Schilling K., Pietsch T. Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells. Am. J. Pathol. 2005, 166:1153-1162.
36. Hatton B.A., Villavicencio E.H., Pritchard J., LeBlanc M., Hansen S., Ulrich M., Ditzler S., Pullar B., Stroud M.R., Olson J.M. Notch signaling is not essential in sonic hedgehog-activated medulloblastoma. Oncogene 2010, 29:3865-3872.
37. Hegde G.V., Munger C.M., Emanuel K., Joshi A.D., Greiner T.C., Weisenburger D.D., Vose J.M., Joshi S.S. Targeting of sonic hedgehog-GLI signaling: A potential strategy to improve therapy for mantle cell lymphoma. Mol. Cancer Ther. 2008, 7:1450-1460.
38. Hegde G.V., Peterson K.J., Emanuel K., Mittal A.K., Joshi A.D., Dickinson J.D., Kollessery G.J., Bociek R.G., Bierman P., Vose J.M., Weisenburger D.D., Joshi S.S. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: A potential new therapeutic target. Mol. Cancer Res. 2008, 6:1928-1936.
39. Hofbauer S.W., Pinon J.D., Brachtl G., Haginger L., Wang W., Johrer K., Tinhofer I., Hartmann T.N., Greil R. Modifying akt signaling in B-cell chronic lymphocytic leukemia cells. Cancer Res. 2010, 70:7336-7344.
40. Hofmann I., Stover E.H., Cullen D.E., Mao J., Morgan K.J., Lee B.H., Kharas M.G., Miller P.G., Cornejo M.G., Okabe R., Armstrong S.A., Ghilardi N., et al. Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell 2009, 4:559-567.
41. Huangfu D., Anderson K.V. Signaling from Smo to Ci/Gli: Conservation and divergence of Hedgehog pathways from Drosophila to vertebrates. Development 2006, 133:3-14.
42. Huangfu D., Liu A., Rakeman A.S., Murcia N.S., Niswander L., Anderson K.V. Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature 2003, 426:83-87.
43. Humke E.W., Dorn K.V., Milenkovic L., Scott M.P., Rohatgi R. The output of Hedgehog signaling is controlled by the dynamic association between Suppressor of Fused and the Gli proteins. Genes Dev. 2010, 24:670-682.
44. Hyman J.M., Firestone A.J., Heine V.M., Zhao Y., Ocasio C.A., Han K., Sun M., Rack P.G., Sinha S., Wu J.J., Solow-Cordero D.E., Jiang J., et al. Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade. Proc. Natl. Acad. Sci. USA 2009, 106:14132-14137.
45. Ikram M.S., Neill G.W., Regl G., Eichberger T., Frischauf A.M., Aberger F., Quinn A., Philpott M. GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter. J. Invest. Dermatol. 2004, 122:1503-1509.
46. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev. 2001, 15:3059-3087.
47. Ingham P.W., Nakano Y., Seger C. Mechanisms and functions of Hedgehog signalling across the metazoa. Nat. Rev. Genet. 2011, 12:393-406.
48. Ji Z., Mei F.C., Xie J., Cheng X. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells. J. Biol. Chem. 2007, 282:14048-14055.
49. Ju B., Spitsbergen J., Eden C.J., Taylor M.R., Chen W. Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish. Mol. Cancer 2009, 8:40.
50. Julian E., Dave R.K., Robson J.P., Hallahan A.R., Wainwright B.J. Canonical Notch signaling is not required for the growth of Hedgehog pathway-induced medulloblastoma. Oncogene 2010, 29:3465-3476.
51. Kappes D.J., He X. CD4-CD8 lineage commitment: An inside view. Nat. Immunol. 2005, 6:761-766.
52. Kasper M., Regl G., Frischauf A.M., Aberger F. GLI transcription factors: Mediators of oncogenic Hedgehog signalling. Eur. J. Cancer 2006, 42:437-445.
53. Kasper M., Schnidar H., Neill G.W., Hanneder M., Klingler S., Blaas L., Schmid C., Hauser-Kronberger C., Regl G., Philpott M.P., Aberger F. Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Mol. Cell. Biol. 2006, 26:6283-6298.
54. Kim J.E., Singh R.R., Cho-Vega J.H., Drakos E., Davuluri Y., Khokhar F.A., Fayad L., Medeiros L.J., Vega F. Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma. Mod. Pathol. 2009, 22:1312-1320.
55. Kim J., Lee J.J., Gardner D., Beachy P.A. Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. Proc. Natl. Acad. Sci. USA 2010, 107:13432-13437.
56. Kim J., Tang J.Y., Gong R., Lee J.J., Clemons K.V., Chong C.R., Chang K.S., Fereshteh M., Gardner D., Reya T., Liu J.O., Epstein E.H., et al. Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell 2010, 17:388-399.
57. -/- repopulating cells. Blood 2004, 104:1002-1009.
58. Kovacs J.J., Whalen E.J., Liu R., Xiao K., Kim J., Chen M., Wang J., Chen W., Lefkowitz R.J. Beta-arrestin-mediated localization of smoothened to the primary cilium. Science 2008, 320:1777-1781.
59. Kurtova A.V., Balakrishnan K., Chen R., Ding W., Schnabl S., Quiroga M.P., Sivina M., Wierda W.G., Estrov Z., Keating M.J., Shehata M., Jager U., et al. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: Development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 2009, 114:4441-4450.
60. Laner-Plamberger S., Kaser A., Paulischta M., Hauser-Kronberger C., Eichberger T., Frischauf A.M. Cooperation between GLI and JUN enhances transcription of JUN and selected GLI target genes. Oncogene 2009, 28:1639-1651.
61. Lau J., Kawahira H., Hebrok M. Hedgehog signaling in pancreas development and disease. Cell. Mol. Life Sci. 2006, 63:642-652.
62. Lauth M., Bergstrom A., Shimokawa T., Toftgard R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc. Natl. Acad. Sci. USA 2007, 104:8455-8460.
63. Lauth M., Bergstrom A., Toftgard R. Phorbol esters inhibit the Hedgehog signalling pathway downstream of Suppressor of Fused, but upstream of Gli. Oncogene 2007, 26:5163-5168.
64. Lauth M., Bergstrom A., Shimokawa T., Tostar U., Jin Q., Fendrich V., Guerra C., Barbacid M., Toftgard R. DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS. Nat. Struct. Mol. Biol. 2010, 17:718-725.
65. Lin T.L., Wang Q.H., Brown P., Peacock C., Merchant A.A., Brennan S., Jones E., McGovern K., Watkins D.N., Sakamoto K.M., Matsui W. Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926. PLoS One 2010, 5:e15262.
66. Lowrey J.A., Stewart G.A., Lindey S., Hoyne G.F., Dallman M.J., Howie S.E., Lamb J.R. Sonic hedgehog promotes cell cycle progression in activated peripheral CD4(+) T lymphocytes. J. Immunol. 2002, 169:1869-1875.
67. Mao J., Maye P., Kogerman P., Tejedor F.J., Toftgard R., Xie W., Wu G., Wu D. Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1. J. Biol. Chem. 2002, 277:35156-35161.
68. Meloni A.R., Fralish G.B., Kelly P., Salahpour A., Chen J.K., Wechsler-Reya R.J., Lefkowitz R.J., Caron M.G. Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2. Mol. Cell. Biol. 2006, 26:7550-7560.
69. Merchant A., Joseph G., Wang Q., Brennan S., Matsui W. Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. Blood 2010, 115:2391-2396.
70. Merkel O., Heyder C., Asslaber D., Hamacher F., Tinhofer I., Holler C., Stocher M., Prokesch A., Papak C., Scheideler M., Trajanoski Z., Greil R. Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13. J. Mol. Med. (Berl) 2008, 86:541-552.
71. Milenkovic L., Scott M.P., Rohatgi R. Lateral transport of Smoothened from the plasma membrane to the membrane of the cilium. J. Cell Biol. 2009, 187:365-374.
72. Mimeault M., Johansson S.L., Vankatraman G., Moore E., Henichart J.P., Depreux P., Lin M.F., Batra S.K. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells. Mol. Cancer Ther. 2007, 6:967-978.
73. Nicolas M., Wolfer A., Raj K., Kummer J.A., Mill P., van Noort M., Hui C.C., Clevers H., Dotto G.P., Radtke F. Notch1 functions as a tumor suppressor in mouse skin. Nat. Genet. 2003, 33:416-421.
74. Nolan-Stevaux O., Lau J., Truitt M.L., Chu G.C., Hebrok M., Fernandez-Zapico M.E., Hanahan D. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev. 2009, 23:24-36.
75. Nusslein-Volhard C., Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 1980, 287:795-801.
76. Outram S.V., Varas A., Pepicelli C.V., Crompton T. Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte. Immunity 2000, 13:187-197.
77. Palma V., Ruiz i Altaba A. Hedgehog-GLI signaling regulates the behavior of cells with stem cell properties in the developing neocortex. Development 2004, 131:337-345.
78. Pasca di Magliano M., Sekine S., Ermilov A., Ferris J., Dlugosz A.A., Hebrok M. Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev. 2006, 20:3161-3173.
79. Pazour G.J., Witman G.B. The vertebrate primary cilium is a sensory organelle. Curr. Opin. Cell Biol. 2003, 15:105-110.
80. Peacock C.D., Wang Q., Gesell G.S., Corcoran-Schwartz I.M., Jones E., Kim J., Devereux W.L., Rhodes J.T., Huff C.A., Beachy P.A., Watkins D.N., Matsui W. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc. Natl. Acad. Sci. USA 2007, 104:4048-4053.
81. Philipp M., Fralish G.B., Meloni A.R., Chen W., MacInnes A.W., Barak L.S., Caron M.G. Smoothened signaling in vertebrates is facilitated by a G protein-coupled receptor kinase. Mol. Biol. Cell 2008, 19:5478-5489.
82. Price M.A., Kalderon D. Proteolysis of the Hedgehog signaling effector Cubitus interruptus requires phosphorylation by Glycogen Synthase Kinase 3 and Casein Kinase 1. Cell 2002, 108:823-835.
83. Rao G., Pedone C.A., Del Valle L., Reiss K., Holland E.C., Fults D.W. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 2004, 23:6156-6162.
84. Regl G., Neill G.W., Eichberger T., Kasper M., Ikram M.S., Koller J., Hintner H., Quinn A.G., Frischauf A.M., Aberger F. Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma. Oncogene 2002, 21:5529-5539.
85. Regl G., Kasper M., Schnidar H., Eichberger T., Neill G.W., Philpott M.P., Esterbauer H., Hauser-Kronberger C., Frischauf A.M., Aberger F. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res. 2004, 64:7724-7731.
86. Riobo N.A., Haines G.M., Emerson C.P. Protein kinase C-delta and mitogen-activated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling. Cancer Res. 2006, 66:839-845.
87. Riobo N.A., Lu K., Ai X., Haines G.M., Emerson C.P. Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proc. Natl. Acad. Sci. USA 2006, 103:4505-4510.
88. Rohatgi R., Milenkovic L., Scott M.P. Patched1 regulates hedgehog signaling at the primary cilium. Science 2007, 317:372-376.
89. Romer J.T., Kimura H., Magdaleno S., Sasai K., Fuller C., Baines H., Connelly M., Stewart C.F., Gould S., Rubin L.L., Curran T. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 2004, 6:229-240.
90. Rowbotham N.J., Hager-Theodorides A.L., Cebecauer M., Shah D.K., Drakopoulou E., Dyson J., Outram S.V., Crompton T. Activation of the Hedgehog signaling pathway in T-lineage cells inhibits TCR repertoire selection in the thymus and peripheral T-cell activation. Blood 2007, 109:3757-3766.
91. Rudin C.M., Hann C.L., Laterra J., Yauch R.L., Callahan C.A., Fu L., Holcomb T., Stinson J., Gould S.E., Coleman B., LoRusso P.M., Von Hoff D.D., et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N. Engl. J. Med. 2009, 361:1173-1178.
92. Ruiz i Altaba A., Sanchez P., Dahmane N. Gli and hedgehog in cancer: Tumours, embryos and stem cells. Nat. Rev. Cancer 2002, 2:361-372.
93. Ruiz i Altaba A., Mas C., Stecca B. The Gli code: An information nexus regulating cell fate, stemness and cancer. Trends Cell Biol. 2007, 17:438-447.
94. Sacedon R., Diez B., Nunez V., Hernandez-Lopez C., Gutierrez-Frias C., Cejalvo T., Outram S.V., Crompton T., Zapata A.G., Vicente A., Varas A. Sonic hedgehog is produced by follicular dendritic cells and protects germinal center B cells from apoptosis. J. Immunol. 2005, 174:1456-1461.
95. Sanchez P., Ruiz i Altaba A. In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice. Mech. Dev. 2005, 122:223-230.
96. Sawyers C.L. The Bcr-Abl gene in chronic myelogenous leukaemia. Cancer Surv. 1992, 15:37-51.
97. Scales S.J., de Sauvage F.J. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol. Sci. 2009, 30:303-312.
98. Schmid C., Isaacson P.G. Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): An immunophenotypic study. Histopathology 1994, 24:445-451.
99. Schnidar H., Eberl M., Klingler S., Mangelberger D., Kasper M., Hauser-Kronberger C., Regl G., Kroismayr R., Moriggl R., Sibilia M., Aberger F. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway. Cancer Res. 2009, 69:1284-1292.
100. Sengupta A., Banerjee D., Chandra S., Banerji S.K., Ghosh R., Roy R., Banerjee S. Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia 2007, 21:949-955.
101. Siggins S.L., Nguyen N.Y., McCormack M.P., Vasudevan S., Villani R., Jane S.M., Wainwright B.J., Curtis D.J. The Hedgehog receptor Patched1 regulates myeloid and lymphoid progenitors by distinct cell-extrinsic mechanisms. Blood 2009, 114:995-1004.
102. Singh R.R., Cho-Vega J.H., Davuluri Y., Ma S., Kasbidi F., Milito C., Lennon P.A., Drakos E., Medeiros L.J., Luthra R., Vega F. Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res. 2009, 69:2550-2558.
103. Singh R.R., Kim J.E., Davuluri Y., Drakos E., Cho-Vega J.H., Amin H.M., Vega F. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia 2010, 24:1025-1036.
104. Singh R.R., Kunkalla K., Qu C., Schlette E., Neelapu S.S., Samaniego F., Vega F. ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma. Oncogene 2011, 30(49):4874-4886.
105. Skvara H., Kalthoff F., Meingassner J.G., Wolff-Winiski B., Aschauer H., Kelleher J.F., Wu X., Pan S., Mickel L., Schuster C., Stary G., Jalili A., et al. Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor. J. Invest. Dermatol. 2011, 131:1735-1744.
106. Stanton B.Z., Peng L.F., Maloof N., Nakai K., Wang X., Duffner J.L., Taveras K.M., Hyman J.M., Lee S.W., Koehler A.N., Chen J.K., Fox J.L., et al. A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat. Chem. Biol. 2009, 5:154-156.
107. Stecca B., Ruiz I.A.A. Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J. Mol. Cell Biol. 2010, 2:84-95.
108. Stecca B., Ruiz i Altaba A. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J. 2009, 28:663-676.
109. Stecca B., Mas C., Clement V., Zbinden M., Correa R., Piguet V., Beermann F., Ruiz I.A.A. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc. Natl. Acad. Sci. USA 2007, 104:5895-5900.
110. + T cells. J. Immunol. 2002, 169:5451-5457.
111. Taipale J., Chen J.K., Cooper M.K., Wang B., Mann R.K., Milenkovic L., Scott M.P., Beachy P.A. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 2000, 406:1005-1009.
112. Taipale J., Cooper M.K., Maiti T., Beachy P.A. Patched acts catalytically to suppress the activity of Smoothened. Nature 2002, 418:892-897.
113. Takebe N., Harris P.J., Warren R.Q., Ivy S.P. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat. Rev. Clin. Oncol. 2011, 8:97-106.
114. Teglund S., Toftgard R. Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim. Biophys. Acta 2010, 1805:181-208.
115. Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts D.J., Lauwers G.Y., Qi Y.P., Gysin S., Fernandez-del Castillo C., Yajnik V., Antoniu B., McMahon M., et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003, 425:851-856.
116. Tremblay M.R., Lescarbeau A., Grogan M.J., Tan E., Lin G., Austad B.C., Yu L.C., Behnke M.L., Nair S.J., Hagel M., White K., Conley J., et al. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926). J. Med. Chem. 2009, 52:4400-4418.
117. Trowbridge J.J., Scott M.P., Bhatia M. Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. Proc. Natl. Acad. Sci. USA 2006, 103:14134-14139.
118. Tukachinsky H., Lopez L.V., Salic A. A mechanism for vertebrate Hedgehog signaling: Recruitment to cilia and dissociation of SuFu-Gli protein complexes. J. Cell Biol. 2010, 191:415-428.
119. Uhmann A., Dittmann K., Nitzki F., Dressel R., Koleva M., Frommhold A., Zibat A., Binder C., Adham I., Nitsche M., Heller T., Armstrong V., et al. The Hedgehog receptor Patched controls lymphoid lineage commitment. Blood 2007, 110:1814-1823.
120. Uhmann A., van den Brandt J., Dittmann K., Hess I., Dressel R., Binder C., Luhder F., Christiansen H., Fassnacht M., Bhandoola A., Wienands J., Reichardt H.M., Hahn H. T cell development critically depends on prethymic stromal patched expression. J. Immunol. 2011, 186:3383-3391.
121. Varjosalo M., Taipale J. Hedgehog signaling. J. Cell Sci. 2007, 120:3-6.
122. Varjosalo M., Bjorklund M., Cheng F., Syvanen H., Kivioja T., Kilpinen S., Sun Z., Kallioniemi O., Stunnenberg H.G., He W.W., Ojala P., Taipale J. Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling. Cell 2008, 133:537-548.
123. Von Hoff D.D., LoRusso P.M., Rudin C.M., Reddy J.C., Yauch R.L., Tibes R., Weiss G.J., Borad M.J., Hann C.L., Brahmer J.R., Mackey H.M., Lum B.L., et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N. Engl. J. Med. 2009, 361:1164-1172.
124. Wang B., Fallon J.F., Beachy P.A. Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 2000, 100:423-434.
125. Wen X., Lai C.K., Evangelista M., Hongo J.A., de Sauvage F.J., Scales S.J. Kinetics of hedgehog-dependent full-length Gli3 accumulation in primary cilia and subsequent degradation. Mol. Cell. Biol. 2010, 30:1910-1922.
126. Whisenant T.C., Ho D.T., Benz R.W., Rogers J.S., Kaake R.M., Gordon E.A., Huang L., Baldi P., Bardwell L. Computational prediction and experimental verification of new MAP kinase docking sites and substrates including Gli transcription factors. PLoS Comput. Biol. 2010, 6:e1000908.
127. Williams J.A., Guicherit O.M., Zaharian B.I., Xu Y., Chai L., Wichterle H., Kon C., Gatchalian C., Porter J.A., Rubin L.L., Wang F.Y. Identification of a small molecule inhibitor of the hedgehog signaling pathway: Effects on basal cell carcinoma-like lesions. Proc. Natl. Acad. Sci. USA 2003, 100:4616-4621.
128. Wong S.Y., Seol A.D., So P.L., Ermilov A.N., Bichakjian C.K., Epstein E.H., Dlugosz A.A., Reiter J.F. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat. Med. 2009, 15:1055-1061.
129. Yauch R.L., Gould S.E., Scales S.J., Tang T., Tian H., Ahn C.P., Marshall D., Fu L., Januario T., Kallop D., Nannini-Pepe M., Kotkow K., et al. A paracrine requirement for hedgehog signalling in cancer. Nature 2008, 455:406-410.
130. Yauch R.L., Dijkgraaf G.J., Alicke B., Januario T., Ahn C.P., Holcomb T., Pujara K., Stinson J., Callahan C.A., Tang T., Bazan J.F., Kan Z., et al. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 2009, 326:572-574.
131. Zhao C., Chen A., Jamieson C.H., Fereshteh M., Abrahamsson A., Blum J., Kwon H.Y., Kim J., Chute J.P., Rizzieri D., Munchhof M., VanArsdale T., et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009, 458:776-779.